
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Before starting elacestrant, discuss any questions or concerns with your medical team.What is the recommended dose of Elacestrant?Take one 345 mg tablet once daily. Patients should···【more】
Article source:Captain MedicineRelease date:2026-02-02Recommended:222
Take elacestrant daily and always follow the guidance of your medical team strictly.How Effective is Elacestrant for Treatment?Elacestrant can significantly prolong the progression···【more】
Article source:Captain MedicineRelease date:2026-02-02Recommended:199
Elacestrant is indicated for the treatment of postmenopausal women or adult men with estrogen receptor (ER)-positive malignant tumors.Precautions for Elacestrant UseDyslipidemiaAmo···【more】
Article source:Captain MedicineRelease date:2026-02-02Recommended:195
Anagrelide is indicated to reduce the risk of blood clots in patients with thrombocythemia (an abnormally high platelet count in the blood). Its mechanism of action is to inhibit p···【more】
Article source:Captain MedicineRelease date:2026-01-30Recommended:159
Special caution is required when using anagrelide, as certain drugs may interact with it.What are the drug interactions of Anagrelide?Do not take this medicine with cisapride, dron···【more】
Article source:Captain MedicineRelease date:2026-01-30Recommended:148
Anagrelide may cause a range of side effects during use.What side effects may Anagrelide cause?Inform your doctor promptly if you experience any of the following symptoms that are ···【more】
Article source:Captain MedicineRelease date:2026-01-30Recommended:157
Anagrelide is used to reduce the platelet count in patients with myeloproliferative disorders (platelets are blood cells required for controlling bleeding).What is Anagrelide?Patie···【more】
Article source:Captain MedicineRelease date:2026-01-30Recommended:167
Revumenib (Revuforj) is an oral, first-in-class targeted Menin protein inhibitor indicated for the treatment of relapsed or refractory acute leukemia with specific genetic abnormal···【more】
Article source:Captain MedicineRelease date:2026-01-29Recommended:215
Revumenib (trade name: Revuforj) is an oral, first-in-class targeted Menin inhibitor indicated for the treatment of relapsed or refractory acute leukemia with KMT2A gene rearrangem···【more】
Article source:Captain MedicineRelease date:2026-01-29Recommended:185
Revumenib (trade name: Revuforj) is an oral targeted drug of the Menin inhibitor class, indicated for the treatment of relapsed or refractory acute leukemia with KMT2A gene rearran···【more】
Article source:Captain MedicineRelease date:2026-01-29Recommended:235
Revuforj carries a risk of differentiation syndrome, and patients and their family members should be alert to relevant symptoms during treatment.Precautions for Revuforj Administra···【more】
Article source:Captain MedicineRelease date:2026-01-29Recommended:217
Rivimeinib is available in three tablet strengths: 25 mg, 110 mg, and 160 mg.What are the side effects of Rivimeinib (Revuforj)?The most common side effects of Revuforj include ble···【more】
Article source:Captain MedicineRelease date:2026-01-28Recommended:176
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:[list:visits]2024-09-07
In recent years, Laos has gradually become a major global supply source for generic drugs, leveragin···【more】
Recommended:[list:visits]2026-22-07
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies ···【more】
Recommended:[list:visits]2026-21-07
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was···【more】
Recommended:[list:visits]2026-20-07
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was···【more】
Recommended:[list:visits]2026-17-07
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos'···【more】
Recommended:[list:visits]2026-16-07
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease pa···【more】
Recommended:[list:visits]2026-15-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643